Liver Disease
From the Journals
Model validates use of HCV+ livers for transplant
A multi-institutional team of researchers has developed a mathematical model that shows when hepatitis C–positive-to-negative transplant may...
From the Journals
Risks identified for drug-resistant bacteremia in cirrhosis
Prevalence of multidrug-resistant organism bacteremia was 33% in hospitalized patients with cirrhosis.
From the Journals
Amyloid depleter/antibody duo reduces systemic amyloidosis severity
Small, early clinical trial tests miridesap and dezamizumab.
From the Journals
PBC disease progression no worse for patients with concomitant NAFLD
Immune recruitment into the liver in NAFLD may explain the discrepancy.
From the Journals
VIDEO: Project ECHO would cost-effectively expand HCV treatment
The project is a teletraining model that would increase the efficiency of treatment.
Conference Coverage
The Liver Meeting 2017 NAFLD debrief – key abstracts
WASHINGTON – Nonalcoholic fatty liver disease is a complex disease that involves multiple organ systems.
Conference Coverage
Living liver donation safety supported in single-center study
SCOTTSDALE, ARIZ. - A study has confirmed the finding of previous investigations that living liver donation yielded a low rate of severe...
Conference Coverage
Statin didn’t slow hepatic steatosis in HIV patients
SAN DIEGO – HIV patients taking a statin saw greater hepatic steatosis progression than did placebo patients.
News
FDA approves first two-dose HBV vaccine
FDA approves first new hepatitis B virus vaccine in 25 years
Conference Coverage
Clinical hepatology debrief wraps up 2017 Liver Meeting
Kris V. Kowdley, MD, highlighted notable research presented at the meeting.